MOLECULAR TARGETS FOR THE THERAPEUTIC MANIPULATION OF APOPTOSIS IN BLADDER CANCER

This publication has 109 references indexed in Scilit:

• A novel tumor-specific gene therapy for bladder cancer
  Medical Hypotheses, 1999
• Telomerase activity in patients with transitional cell carcinoma
  Cancer, 1999
• Chromosomal aberrations associated with invasion in papillary superficial bladder cancer
  The Journal of Pathology, 1998
• Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer
  Oncogene, 1998
• A Novel Gene Delivery System Using Urothelial Tissue Engineered Neo-Organs
  Journal of Urology, 1997
• BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
  The Lancet, 1997
• bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer
  International Journal of Cancer, 1996
• Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1994
• Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study
  British Journal of Cancer, 1992
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
  Nature, 1990